Aiforia Technologies Oyj Stock

Equities

AIFORIA

FI4000507934

Software

Market Closed - Nasdaq Helsinki 11:22:44 2024-04-25 am EDT 5-day change 1st Jan Change
3.92 EUR -0.76% Intraday chart for Aiforia Technologies Oyj +4.53% +12.32%
Sales 2024 * 4.3M 4.61M Sales 2025 * 8.1M 8.69M Capitalization 102M 109M
Net income 2024 * -11M -11.8M Net income 2025 * -10M -10.72M EV / Sales 2024 * 24.6 x
Net Debt 2024 * 3.9M 4.18M Net Debt 2025 * 13.6M 14.58M EV / Sales 2025 * 14.3 x
P/E ratio 2024 *
-8.91 x
P/E ratio 2025 *
-10.1 x
Employees 79
Yield 2024 *
-
Yield 2025 *
-
Free-Float 56.79%
More Fundamentals * Assessed data
Dynamic Chart
Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board CI
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow CI
Aiforia Partners with US Nonprofit to Commercialize AI Predicting Colorectal Cancer Recurrence MT
Aiforia Signs a Licensing Agreement with the Mayo Clinic for an AI Model That Improves Prediction of Colorectal Cancer Recurrence CI
Aiforia Technologies Enters Three-year Technology Deal with Italian Hospital MT
Aiforia Signs A Deal with an Italian Hospital in Catania CI
Aiforia Technologies Oyj Announces Appointment of Professor Inti Zlobec to Its Scientific Advisory Board CI
Aiforia Technologies plc Appoints Panu Kauppila as Chief Product Officer and A Member of the Management Team CI
Aiforia Technologies Plc Initiates Path to Secure its First Regulatory Approval in the United States CI
Aiforia Technologies Oyj Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Aiforia Signs Partnership With Orion for AI-based Image Analysis for Preclinical Research MT
Aiforia Technologies Oyj Signs A Major Deal with an Italian Regional Health Authority CI
First NHS Trust Signs Contract to Adopt Aiforia PD-L1 AI Model for Lung Cancer in Clinical Diagnostics CI
Aiforia Technologies plc Approves Executive Changes CI
More news
1 day-0.76%
1 week+4.53%
Current month+3.70%
1 month+10.73%
3 months+4.81%
6 months+12.00%
Current year+12.32%
More quotes
1 week
3.62
Extreme 3.62
3.99
1 month
3.58
Extreme 3.58
4.01
Current year
3.29
Extreme 3.29
4.01
1 year
3.09
Extreme 3.09
5.20
3 years
2.96
Extreme 2.96
5.84
5 years
2.96
Extreme 2.96
5.84
10 years
2.96
Extreme 2.96
5.84
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 15-08-31
Director of Finance/CFO 61 20-12-31
Chief Tech/Sci/R&D Officer 46 16-12-31
Members of the board TitleAgeSince
Chairman 65 13-10-31
Founder 60 13-03-06
Chief Executive Officer 61 15-08-31
More insiders
Date Price Change Volume
24-04-25 3.92 -0.76% 6,527
24-04-24 3.95 +6.76% 9,669
24-04-23 3.7 +1.09% 3,861
24-04-22 3.66 -0.27% 6,840
24-04-19 3.67 -2.13% 6,351

Delayed Quote Nasdaq Helsinki, April 25, 2024 at 11:22 am EDT

More quotes
Aiforia Technologies Oyj is a Finland-based company providing image analysis software utilizing artificial intelligence (AI). Aiforia’s business model is based on the development and utilization of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics. The Company’s cloud-based deep learning artificial intelligence solutions aim to increase the speed, accuracy, and consistency of analyzing medical images across a wide range of fields. Aiforia's solutions aim to automate routine tasks and provide artificial intelligence to support the diagnostic workflow. The product offering consists of Aiforia Create, a solution with which the end user can develop their own AI model for any image analysis application simply by annotating images to train the AI model what to identify, quantify, or measure.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.92 EUR
Average target price
4.2 EUR
Spread / Average Target
+7.14%
Consensus
  1. Stock Market
  2. Equities
  3. AIFORIA Stock